Gryphon Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Buy |
4,250
+23
| +0.5% | +$17.9K | 0.43% | 33 |
|
|
2025
Q1 | $3.49M | Buy |
4,227
+409
| +11% | +$338K | 0.5% | 28 |
|
|
2024
Q4 | $2.95M | Sell |
3,818
-528
| -12% | -$408K | 0.42% | 34 |
|
|
2024
Q3 | $3.85M | Buy |
4,346
+339
| +8% | +$300K | 0.52% | 26 |
|
|
2024
Q2 | $3.63M | Buy |
4,007
+294
| +8% | +$266K | 0.54% | 26 |
|
|
2024
Q1 | $2.89M | Buy |
3,713
+1,389
| +60% | +$1.08M | 0.48% | 27 |
|
|
2023
Q4 | $1.35M | Buy |
2,324
+377
| +19% | +$220K | 0.24% | 62 |
|
|
2023
Q3 | $1.05M | Sell |
1,947
-33
| -2% | -$17.7K | 0.24% | 52 |
|
|
2023
Q2 | $929K | Sell |
1,980
-6
| -0.3% | -$2.81K | 0.2% | 61 |
|
|
2023
Q1 | $682K | Buy |
1,986
+453
| +30% | +$156K | 0.16% | 74 |
|
|
2022
Q4 | $561K | Buy |
1,533
+43
| +3% | +$15.7K | 0.13% | 90 |
|
|
2022
Q3 | $482K | Buy |
1,490
+89
| +6% | +$28.8K | 0.12% | 98 |
|
|
2022
Q2 | $454K | Buy |
1,401
+223
| +19% | +$72.3K | 0.11% | 103 |
|
|
2022
Q1 | $337K | Buy |
1,178
+94
| +9% | +$26.9K | 0.07% | 144 |
|
|
2021
Q4 | $300K | Buy |
1,084
+43
| +4% | +$11.9K | 0.06% | 165 |
|
|
2021
Q3 | $241K | Buy |
1,041
+50
| +5% | +$11.6K | 0.05% | 170 |
|
|
2021
Q2 | $194K | Buy |
+991
| New | +$194K | 0.04% | 163 |
|
|
2018
Q3 | – | Sell |
-1,168
| Closed | -$99K | – | 557 |
|
|
2018
Q2 | $99K | Buy |
1,168
+14
| +1% | +$1.19K | 0.04% | 132 |
|
|
2018
Q1 | $90K | Sell |
1,154
-120
| -9% | -$9.36K | 0.05% | 150 |
|
|
2017
Q4 | $107K | Buy |
+1,274
| New | +$107K | 0.06% | 134 |
|